Pfizer-BioNTech Covid-19 vaccine neutralises Brazil variant in lab study

Pfizer-BioNTech Covid-19 vaccine neutralises Brazil variant in lab study
Pfizer-BioNTech Covid-19 vaccine neutralises Brazil variant in lab study

Hello and welcome to the details of Pfizer-BioNTech Covid-19 vaccine neutralises Brazil variant in lab study and now with the details

Nevin Al Sukari - Sana'a - The scientists said the neutralising ability was roughly equivalent the vaccine’s effect on a previous less contagious version of the virus from last year. — AFP pic

Subscribe to our Telegram channel for the latest updates on news you need to know.


NEW YORK, March 9 — The Covid-19 vaccine from Pfizer Inc and BioNTech SE was able to neutralise a new variant of the coronavirus spreading rapidly in Brazil, according to a labouratory study published in the New England Journal of Medicine yesterday.

Blood taken from people who had been given the vaccine neutralised an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil, the study conducted by scientists from the companies and the University of Texas Medical Branch found.

The scientists said the neutralising ability was roughly equivalent the vaccine’s effect on a previous less contagious version of the virus from last year.

The spike, used by the virus to enter human cells, is the primary target of many Covid-19 vaccines.

In previously published studies, Pfizer had found that its vaccine neutralised other more contagious variants first identified in the United Kingdom and South Africa, although the South African variant may reduce protective antibodies elicited by the vaccine.

Pfizer has said it believes its current vaccine is highly likely to still protect against the South African variant. However, the drugmaker is planning to test a third booster dose of their vaccine as well as a version retooled specifically to combat the variant in order to better understand the immune response. — Reuters

These were the details of the news Pfizer-BioNTech Covid-19 vaccine neutralises Brazil variant in lab study for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Ex-employee kills eight in rampage at US FedEx facility
NEXT Youth join mainstream as India unveils development initiatives in Jammu and Kashmir